American Century Companies’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.52M | Buy |
357,029
+40,821
| +13% | +$631K | ﹤0.01% | 1629 |
|
|
2025
Q1 | $4.7M | Buy |
316,208
+15,121
| +5% | +$225K | ﹤0.01% | 1631 |
|
|
2024
Q4 | $3.99M | Buy |
301,087
+17,103
| +6% | +$226K | ﹤0.01% | 1703 |
|
|
2024
Q3 | $4.04M | Buy |
283,984
+20,993
| +8% | +$299K | ﹤0.01% | 1687 |
|
|
2024
Q2 | $3.4M | Buy |
262,991
+17,363
| +7% | +$225K | ﹤0.01% | 1668 |
|
|
2024
Q1 | $3.41M | Buy |
245,628
+18,606
| +8% | +$258K | ﹤0.01% | 1634 |
|
|
2023
Q4 | $3.24M | Buy |
227,022
+15,088
| +7% | +$215K | ﹤0.01% | 1555 |
|
|
2023
Q3 | $3.28M | Buy |
211,934
+12,647
| +6% | +$196K | ﹤0.01% | 1494 |
|
|
2023
Q2 | $3.13M | Buy |
199,287
+26,553
| +15% | +$417K | ﹤0.01% | 1480 |
|
|
2023
Q1 | $2.82M | Buy |
172,734
+18,914
| +12% | +$309K | ﹤0.01% | 1482 |
|
|
2022
Q4 | $2.4M | Sell |
153,820
-1,505,923
| -91% | -$23.5M | ﹤0.01% | 1496 |
|
|
2022
Q3 | $21.5M | Buy |
1,659,743
+1,557,318
| +1,520% | +$20.2M | 0.02% | 653 |
|
|
2022
Q2 | $1.44M | Buy |
102,425
+31,645
| +45% | +$444K | ﹤0.01% | 1545 |
|
|
2022
Q1 | $1.01M | Buy |
70,780
+8,941
| +14% | +$128K | ﹤0.01% | 1677 |
|
|
2021
Q4 | $843K | Buy |
61,839
+4,945
| +9% | +$67.4K | ﹤0.01% | 1730 |
|
|
2021
Q3 | $932K | Hold |
56,894
| – | – | ﹤0.01% | 1624 |
|
|
2021
Q2 | $958K | Buy |
56,894
+28,436
| +100% | +$479K | ﹤0.01% | 1564 |
|
|
2021
Q1 | $520K | Buy |
28,458
+5,380
| +23% | +$98.3K | ﹤0.01% | 1709 |
|
|
2020
Q4 | $420K | Buy |
23,078
+4,334
| +23% | +$78.9K | ﹤0.01% | 1618 |
|
|
2020
Q3 | $334K | Buy |
18,744
+482
| +3% | +$8.59K | ﹤0.01% | 1510 |
|
|
2020
Q2 | $327K | Buy |
18,262
+5,337
| +41% | +$95.6K | ﹤0.01% | 1421 |
|
|
2020
Q1 | $196K | Buy |
+12,925
| New | +$196K | ﹤0.01% | 1439 |
|